The King's Brief Lnterstitial Lung Disease Questionnaire
Investigation of the Turkish Validity and Reliability of The King's Brief Interstitial Lung Disease Questionnaire (K-BILD) in Individuals With Interstitial Lung Involvement Secondary to Rheumatological Diseases
1 other identifier
observational
45
1 country
1
Brief Summary
The aim of this study is to examine the validity and reliability of the Turkish Validity and Reliability of The King's Brief Interstitial Lung Disease Questionnaire (K-BILD) in Individuals with Interstitial Lung Involvement Secondary to Rheumatological Diseases.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 5, 2026
CompletedFirst Submitted
Initial submission to the registry
July 7, 2026
CompletedFirst Posted
Study publicly available on registry
July 13, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 15, 2027
July 13, 2026
July 1, 2026
6 months
July 7, 2026
July 7, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
King's Brief lnterstitial Lung Disease Questionnaire
It consists of 15 items and has a seven-point Likert scale.
10 minutes
Secondary Outcomes (3)
Arthritis Impact Measurement Scales (AIMS2)-Short Form
15 minutes
Modified Medical Research Council (mMRC) Dyspnea Scale
5 minutes
Visual Analog Scale
3 minutes
Study Arms (1)
Group I
Interstitial Lung Involvement Secondary to Rheumatological Diseases
Interventions
King's Brief lnterstitial Lung Disease Questionnaire, Arthritis Impact Measurement Scales (AIMS2)-Short Form, Modified Medical Research Council (mMRC) Dyspnea Scale, Visual Analog Scale were evaluated.
Eligibility Criteria
All patient-reported outcome measurements will be administered once, and King's Brief Interstitial Lung Disease Questionnaire will be administered twice, one week apart.
You may qualify if:
- Being 18 years of age or older,
- Agreeing to participate in the study.
You may not qualify if:
- Presence of any orthopedic problem that affects functionality
- History of any orthopedic surgery in the last year
- Inability to speak or understand Turkish fluently
- Presence of a psychiatric illness that affects cooperation
- Heart failure that affects daily living activities
- Being a cancer patient
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Usak University
Uşak, Center, 64200, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
July 7, 2026
First Posted
July 13, 2026
Study Start
July 5, 2026
Primary Completion (Estimated)
January 15, 2027
Study Completion (Estimated)
May 15, 2027
Last Updated
July 13, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share